An EMS provider, certified in accordance with section 4765.30 of the Revised Code and Chapter 4765-8 of the Administrative Code, may administer appropriate drugs in response to suspected or known exposure to a nerve or organophosphate agent provided the EMS provider is under physician medical direction and has received appropriate training regarding the administration of such drug. An emergency medical responder or emergency medical technician shall be limited to administration of such drugs from a pre-filled auto-injector.
R.C. 119.032 review dates: 04/16/2014
Promulgated Under: 119.03
Statutory Authority: R.C. 4765.11 , 4765.35 , 4765.37 , 4765.38 , 4765.39
Rule Amplifies: R.C. 4765.35 , 4765.37 , 4765.38 , 4765.39
Prior Effective Dates: 12/30/04, 9/1/05, 7/2/09